Platelet-mediated activation of perivascular mast cells triggers progression of sepsis to septic shock in mice.
Hae Woong Choi, Joo Hwan Noh, Jason Iskarpatyoti, Xiaoyi Zhu, Chunjing Bao, Mathew Abraham, Ulrike Hoffmann, Jamie R Privratsky, Robert H Lee, Wolfgang Bergmeier, Ephraim L Tsalik, Cassandra Fiorino, Junjie Yao, Soman N Abraham, Jörn Karhausen
Abstract
Open AccessThe critical events that trigger sepsis progression into life-threatening septic shock remain unclear. In agreement with reports that link a drop in platelet count to a complicated clinical course in sepsis patients, here we report that, during sepsis, mouse platelets become activated, deposit systemically on vascular walls, and stimulate perivascular mast cells (MC) by releasing platelet activating factor (PAF). In mouse models and patient samples, MC activation correlates with the development of shock in sepsis and is mechanistically linked to shock by inducing systemic hypotension, vascular leakage and microvascular perfusion abnormalities. Preventing platelet or MC activation, or inhibiting the activity of the major MC granule constituent chymase, averts progression from sepsis to shock and reduces mortality of septic mice. Thus, our work establishes that, during sepsis progression, platelet microvascular adhesion leads to MC-mediated vascular changes to culminate in septic shock and septic shock-associated mortality.